keratoacanthoma and the incidence of scc Pages on BioPortfolio:

BioPortfolio - Keratoacanthoma
Keratoacanthoma - BioPortfolio - Indepth. ... KA is an abortive malignancy that rarely progresses into an invasive SCC. The KA may serve as a marker for the ...
http://www.bioportfolio.com/indepth/Keratoacanthoma.html...

BioPortfolio - Keratoacanthoma - InDepth
It is a disease of the elderly with an annual incidence ... KA is an abortive malignancy that rarely progresses into an invasive SCC. ...
http://www.bioportfolio.com/indepth/Keratoacanthoma.pdf...

BioPortfolio - basal cell carcinoma uk
Are Keratoacanthomas Variants of Squamous Cell Carcinomas? A .. ... Cancer Society ... in the pathogenesis of squamous cell carcinoma of the vulva (SCC).
...
http://www.bioportfolio.com/search/basal_cell_carcinoma_uk.h...

BioPortfolio - CDKN2A publications
17198740, By comparing the expression of p53, cyclin D1, p16, hTERT, and TSP-1 in spontaneously regressing keratoacanthoma and squamous cell carcinoma, ...
http://www.bioportfolio.com/gene/1029-CDKN2A/publications.ht...

BioPortfolio - TP53 publications
... may be an early event in the development of AK to cutaneous SCC. ...... 12823440, low incidence for actinic damage, basal cell and squamous cell ...
http://www.bioportfolio.com/gene/7157-TP53/publications.html...

Results from other life science and pharmaceutical sites:

Periocular keratoacanthoma: can we always rely on the clinical ...
The annual incidence of cutaneous keratoacanthoma varies according to geographical ... The distinction between keratoacanthoma and SCC is not always
simple. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=17...

Periocular keratoacanthoma: can we always rely on ...[Br J ...
The final histological diagnosis revealed two cases (16.7%) of invasive SCC, and 10 cases (83.3%) of keratoacanthoma. The lower lid was most commonly ...
http://www.ncbi.nlm.nih.gov/pubmed/16113382...

Journal of Investigative Dermatology - Keratoacanthomas Frequently ...
An increased incidence of keratoacanthoma is seen among immunosuppressed .... The localization of genetic aberrations in all keratoacanthomas and SCC are ...
http://www.nature.com/jid/journal/v119/n6/full/5603347a.html...

Are Keratoacanthomas Variants of Squamous Cell Carcinomas? A ...
KA, keratoacanthoma. SCC, squamous cell carcinoma ... Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=24...

Modern Pathology - Comparison of Oncostatin M Expression in ...
To determine whether keratoacanthoma (KA) is unique or a variant of .... Langerhans' cells (37) in KA compared with SCC, and a high incidence of KAs in
...
http://www.nature.com/modpathol/journal/v13/n4/full/3880073a...

Development of Keratoacanthomas and Squamous Cell Carcinomas in ...
23 Although keratoacanthoma resembles SCC histologically and can ... 24 In correlation with this, a relatively high incidence of the mutated Ha-ras
oncogene ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18...

Journal of Investigative Dermatology - Are Keratoacanthomas ...
CGH, comparative genomic hybridization; KA, keratoacanthoma; SCC, ... 1971), and shows increased incidence among immunosuppressed patients (Sullivan and ...
http://www.nature.com/jid/journal/v126/n10/full/5700375a.htm...

Journal of Investigative Dermatology - The Increased Risk of Skin ...
We determined the incidence of SCC and BCC counting all tumors in the ... Only biopsy confirmed SCC (not including SCC in situ or keratoacanthoma) or BCC ...
http://www.nature.com/jid/journal/v121/n2/full/5601874a.html...

Malignant Cutaneous Tumors: Malignant Tumors of the Epidermis
In Australia, for example, the incidence of SCC increased by 51% between the years 1985 and ... The differential diagnosis of SCC includes keratoacanthoma,
...
http://www.medscape.com/viewarticle/535265?rss...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.